期刊文献+

腹腔镜经尾侧-中间联合入路治疗右半结肠癌的疗效分析 被引量:5

Efficacy of LaparoscopicCaudal-intermediate Combined Approach in the Treatment of Right Colon Cancer
下载PDF
导出
摘要 目的比较腹腔镜经中间入路、尾侧-中间联合入路治疗右半结肠癌的疗效,以及对胃肠激素、免疫指标、人衰老关键蛋白1(FBLN1)、糖类抗原199(CA199)、钙结合蛋白S100A9(S100A9)的影响。方法将2018年1月至2021年5月成都市第三人民医院右半结肠癌患者109例作为研究对象,根据手术入路方式不同分为两组,对照组55例,经中间入路开展腹腔镜治疗,试验组54例,经尾侧-中间联合入路开展腹腔镜治疗,比较两组围手术期各项指标及术后14 d的免疫功能、胃肠激素、肿瘤相关因子和术后并发症。结果两组术中出血量、术后并发症发生率、手术时长、淋巴结清扫数差异无统计学意义(P>0.05)。试验组首次排气时间短于对照组(P<0.05),术后14 d的调节性T细胞(Tregs)、辅助性T细胞Th17、Th2、S100A9、CA199低于对照组(P<0.05),术后14 d的FBLN1、Th1高于对照组(P<0.05)。同时试验组术后1、14 d的抑胃肽、胃动素、胃泌素高于对照组(P<0.05)。结论经尾侧-中间联合入路对右半结肠癌患者进行腹腔镜治疗,能够减轻手术对免疫功能和胃肠道功能的影响,促进术后肠功能恢复,改善肿瘤相关因子。 Objective To compare the efficacy of laparoscopic medial approach and combined caudal-intermediate approach in the treatment of right colon cancer and their influence on gastrointestinal hormones,immune indicators,human aging key protein 1(FBLN1),carbohydrate antigen 199(CA199),and calcium binding protein S100A9(S100A9).Methods A total of 109 patients with right colon cancer in the Third People′s Hospital of Chengdu from January 2018 to May 2021 were selected as the research objects.According to different approaches of laparoscopic-assisted right hemicolectomy,the patients were divided into two groups:control group(intermediate approach,n=55)and experimental group(combined caudal-intermediate approach,n=54).Perioperative indexes,postoperative complications and immune function,gastrointestinal hormones,and tumor-related factors 14 d after operation were compared between the two groups.Results There were no significant differences in intraoperative blood loss,incidence of postoperative complications,duration of operation,and number of lymph node dissected(P>0.05).The first exhaust time in the experimental group was shorter than that in the control group(P<0.05).On the 14th day after operation,regulatory T cells(Tregs),helper T cells Th17 and Th2,S100A9 and CA199 in the experimental group were lower than those in the control group(P<0.05);FBLN1 and Th1 in the experimental group were higher than those in the control group(P<0.05).At the same time,gastric inhibitory peptide(GIP),motilin(MTL)and gastrin(GAS)on the 1st and 14th day after operation in in the experimental group were higher than those in the control group(P<0.05).Conclusion Laparoscopic-assisted right hemicolectomy with combined caudal-intermediate approach can reduce the impact on immune function and gastrointestinal function,promote the recovery of postoperative intestinal function,and improve tumor-related factors.
作者 古建辉 李云涛 王蒙 张晓洁 Gu Jianhui;Li Yuntao;Wang Meng;Zhang Xiaojie(Section for Gastrointestinal Surgery,Department of General Surgery,The Third People′s Hospital of Chengdu,Chengdu 610031,China;Department of Biochemistry and Molecular Biology,Bengbu Medical College,Bengbu 233000,China)
出处 《成都医学院学报》 CAS 2022年第4期468-472,共5页 Journal of Chengdu Medical College
基金 四川省卫生健康委员会医学科技项目(No:21PJ147)。
关键词 腹腔镜 尾侧-中间联合入路 右半结肠癌 胃肠激素 免疫功能 人衰老关键蛋白1 Laparoscopy Combined caudal-intermediate approach Right colon cancer Gastrointestinal hormone Immune function Human aging key protein 1
  • 相关文献

参考文献16

二级参考文献119

  • 1王驰,谢鹏雁.息肉切除术后随访指南——美国结直肠癌多中心工作组和美国癌症协会的最新共识(2006)[J].中国内镜杂志,2007,13(6):668-671. 被引量:5
  • 2NCCN.NCCN结肠癌临床实践指南[EB/OL].(2005-02-05)[2010-02-25].http://www.nccn.org/professionals/physician_gls/PDF/colon.pal.
  • 3Jayne D G, Guillou, Thorpe H, et al. Randomized trial of laparoscopic--assisted resection of colorectal carcinoma: 3--year results of the UK MRC CLASICC trial group[J]. J Clin Oncol,2007,25: 3061-3068.
  • 4Kuhry E, Bonjer H J, Haglind E, et al. Impact of hospital case volume on short--term outcome after laparoscopic operation for colonic cancer[J]. Surg Endosc, 2005,19:687--692.
  • 5Johnson P M, Porter G A, Ricciardi R , et al. Increasing negative lymph node count is independently associated with improved long term survival in stage IIIB and IIIC colon cancer[J]. J Clin Oncol, 2006,24:3570--3575.
  • 6Berger A C, Sigurdson E R, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes[J]. J Clin Oncol,2005,23:8706--8712.
  • 7Yasuda K, Adachi Y, Shiraishi N, et al. Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer [J]. Ann Surg Oncol, 2001,8:300--304.
  • 8Sargent D, Sobrero A, Grothey A, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20 898 patients on 18 randomized trials[J]. J Clin Oncol, 2009,27 : 872- 877.
  • 9Gray R, Barnwell J, McConkey C, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study[J]. Lancet, 2007,370 : 2020-- 2029.
  • 10Andre T, Boni C, Navarro M,et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial[J]. J Clin Oncol, 2009,27(19):3109-3116.

共引文献459

同被引文献55

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部